If you were granted one wish, what would you wish for? For many, it would be to bring someone back from the dead or maybe even to avoid death themselves. Well, it seems that this is one wish that may just be granted in the near future.
Dr. Ira Pastor, CEO of Bioquark, has called it the “possible reversal of death”. Their process begins with the first phase of the clinical trial, recently approved in April. In a brain dead state, the body is still able to perform many normal functions, such as metabolism, growth, and digestion. This is why the researchers believe that repairing the brain could lead to restoring life in the patient.
The clinical trial will follow 20 clinically brain dead individuals for several months after a six week period of treatment. The 20 individuals will receive one of four treatments. All of these treatments combine procedures that are currently used for stimulation or regeneration of other systems in the body. The first is an injection of various protein chains, called peptides, injected daily to the spinal cord. The second is injections of stem cells directly to the brain on a daily basis. The last two are non-invasive, one being a transcranial laser therapy, and the other an electrical impulse applied to the median nerve in the upper limbs.
Since this is only the first stage of testing, Pastor and his partner – a specialist in India, Himanshu Bansal MD – are not looking for full revitalization of the brain directly from this study. Instead they are looking for an increase in the patient's pulse, blood oxygen saturation, blood pressure, and respiration. These results would indicate success with one of the four treatments and would lead to future areas of research to one day have full recovery of brain death.
This clinical trial is the first step in discovering a way to save millions of lives by reversing the state of brain dead individuals. The ability to revive the central nervous system would not only give us an insight to the state of brain death and consciousness, but would also have the ability to treat degenerative disorders of the central nervous system, such as Alzheimer’s and Parkinson’s disease. These findings have the potential to change how we perceive death and could drastically impact our understanding of the brain – one of the most mysterious parts of the body.